Patents Assigned to MESTEX AG

COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL

Publication number: 20220008384

Abstract: A composition comprising capsaicin or a capsacinoid is used in a method for postoperative pain control. The composition is administered to a site intended for surgery in a patient at least one day before surgery is actually performed.

Type: Application

Filed: September 27, 2021

Publication date: January 13, 2022

Applicant: MESTEX AG

Inventors: Christian GERBER, Thomas GILLER, Olivier VALDENAIRE
RESINIFERATOXIN SOLUTION

Publication number: 20150190509

Abstract: The invention relates to a resiniferatoxin solution having an enhanced storage stability, in which the resiniferatoxin is dissolved in a body-compatible solvent which contains a protective gas in solution, wherein the amount of the protective gas is at least 1 wt % of the saturation amount of the protective gas in the solvent at ambient temperature and normal pressure. The resiniferatoxin dissolved in the resiniferatoxin solution remains stable for a relatively long period and exhibits a reduced tendency to cling to polymeric surfaces.

Type: Application

Filed: August 3, 2012

Publication date: July 9, 2015

Applicant: MESTEX AG

Inventor: Thomas Giller
Use of resiniferatoxin (RTX) for producing an agent for treating joint pains and method for applying said agent

Patent number: 9044452

Abstract: A method for treating a joint affected by pain that involves injecting an agent that includes resiniferatoxin (RTX) dissolved in a physiologically suitable solvent locally into the intracapsular region or the bursa of the joint affected by pain.

Type: Grant

Filed: April 7, 2010

Date of Patent: June 2, 2015

Assignee: MESTEX AG

Inventor: Dominik Meyer
Method of treating articular pain using a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan

Patent number: 8703741

Abstract: The invention relates to the use of a vanilloid receptor agonist together with a glycosaminoglycan for producing an agent for treating pain.

Type: Grant

Filed: December 28, 2004

Date of Patent: April 22, 2014

Assignee: Mestex AG

Inventor: Dominik Meyer
Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means

Patent number: 7964644

Abstract: The invention relates to using neurotoxic substances which in particular are toxic to the axons and to the nociceptive nerve endings in the preparations of agents treating joint pains.

Type: Grant

Filed: July 19, 2002

Date of Patent: June 21, 2011

Assignee: MESTEX AG

Inventor: Dominik Meyer
USE OF RESINIFERATOXIN (RTX) FOR PRODUCING AN AGENT FOR TREATING JOINT PAINS AND METHOD FOR APPLYING SAID AGENT

Publication number: 20100196281

Abstract: A method for treating a joint affected by pain that involves injecting an agent that includes resiniferatoxin (RTX) dissolved in a physiologically suitable solvent locally into the intracapsular region or the bursa of the joint affected by pain.

Type: Application

Filed: April 7, 2010

Publication date: August 5, 2010

Applicant: MESTEX AG

Inventor: Dominik Meyer
MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER

Publication number: 20100047181

Abstract: The following abstract will replace all prior versions of the abstract in the application: The mixture comprises a vanilloid receptor agonist with a substance, which inhibits nerve regeneration. The mixture is suitable for use, especially, as a painkiller.

Type: Application

Filed: December 22, 2004

Publication date: February 25, 2010

Applicant: MESTEX AG

Inventor: Dominik Meyer
Use Of A Vanilloid Receptor Agonist Together With A Glycosaminoglycan Or Proteoglycan For Producing An Agent For Treating Articular Pains And Method For Applying Said Agent

Publication number: 20080153780

Abstract: The invention relates to the use of a vanilloid receptor agonist together with a glycosaminoglycan for producing an agent for treating pain.

Type: Application

Filed: December 28, 2004

Publication date: June 26, 2008

Applicant: MESTEX AG

Inventor: Dominik Meyer
Use Of Resiniferatoxin (Rtx) For Producing An Agent For Treating Joint Pains And Method For Applying Said Agent

Publication number: 20080139641

Abstract: The use of resiniferatoxin (RTX) relates to a formulation, which does not contain any local anesthetic and preferably also no other pharmacologically active substances, for the preparation of an agent for the treatment of different pain conditions.

Type: Application

Filed: December 28, 2004

Publication date: June 12, 2008

Applicant: MESTEX AG

Inventor: Dominik Meyer
Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means

Publication number: 20050215633

Abstract: The invention relates to using neurotoxic substances which in particular are toxic to the axons and to the nociceptive nerve endings in the preparations of agents treating joint pains.

Type: Application

Filed: July 19, 2002

Publication date: September 29, 2005

Applicant: Mestex Ag

Inventor: Dominik Meyer